Journal article icon

Journal article

A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapine.

Abstract:

OBJECTIVE: To assess whether clozapine is likely to be more cost-effective than other second-generation antipsychotics (SGAs) in people with schizophrenia. METHODS: An integrated clinical and economic multicenter, rater-blind, randomized controlled trial (RCT) compared clozapine to the class of other SGAs, using the perspectives of the National Health Service, social support services, and patients. The practice setting was secondary and primary care in the United Kingdom; patients were follo...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Expand authors...
Journal:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Volume:
11
Issue:
4
Pages:
549-562
Publication date:
2008-01-01
DOI:
EISSN:
1524-4733
ISSN:
1098-3015
URN:
uuid:7408c1fb-5e95-4226-b724-a29ea5146f7e
Source identifiers:
584
Local pid:
pubs:584

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP